Phillip Levine

机构：Sanofi (United States)

发表论文 15 篇 · 总被引 214 次 · h-index 5

代表论文

• Risankizumab for Ulcerative Colitis (2024 · JAMA · 被引 126)
• Reflux Events Detected by pH‐MII Do Not Determine Fundoplication Outcome (2010 · Journal of Pediatric Gastroenterology and Nutrition · 被引 54)
• S845 Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study (2023 · The American Journal of Gastroenterology · 被引 8)
• Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 6)
• Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 6)
• Histomoniasis in a kidney of a turkey. (1947 · PubMed · 被引 5)